ALK and lymphoma: We further confirmed that these autoantibodies were specific for the ALK intracellular domain using Western blots with lymphoma cells where the expression of the endogenous NPM-ALK was knocked down with a doxycycline-inducible ALK shRNA (Supplementary Figure 4).